NRX Pharmaceuticals, Inc. (NRXP): DEFA14A filed Nov 5, 2026

Form type

DEFA14A

Filing date

Nov 5, 2026

Accession number

0001437749-26-035308

Filer

NRX Pharmaceuticals, Inc. (CIK 1719406)